Verve Therapeutics, Inc. (29) | Uncategorized (4)
Recent Contracts
-
Description of Securities Registered under Section 12 of the Exchange Act
(Filed With SEC on March 14, 2022)
-
Offer Letter, dated as of April 16, 2019, by and between the Registrant and Sekar Kathiresan, M.D
(Filed With SEC on May 28, 2021)
-
Offer Letter, dated as of July 26, 2019, by and between the Registrant and Andrew Ashe, J.D
(Filed With SEC on May 28, 2021)
-
Offer Letter, dated as of July 26, 2019, by and between the Registrant and Andrew Bellinger, M.D., Ph.D
(Filed With SEC on May 28, 2021)